(1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
申请人:Cole Derek Cecil
公开号:US06951881B2
公开(公告)日:2005-10-04
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物,以及其在治疗与或受5-HT6受体相关的疾病中的应用。
US6951881B2
申请人:——
公开号:US6951881B2
公开(公告)日:2005-10-04
(1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
申请人:Wyeth
公开号:US20030232843A1
公开(公告)日:2003-12-18
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
1